EMA Authorised: Zoledronic Acid Hospira (zoledronic acid monohydrate) — Pfizer Europe MA EEIG

View source ↗

Summary

EU authorises Zoledronic Acid Hospira (zoledronic acid monohydrate) for hypercalcemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia

Drugs mentioned

• Zoledronic Acid Hospira (zoledronic acid monohydrate)

Snippet

Status: Authorised. Therapeutic area: Hypercalcemia. MAH: Pfizer Europe MA EEIG. Decision date: 01/10/2021